LBPH stock gains as investors weigh Nasdaq pricing
Published on 09/02/2026 at 16:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSLBPH stock (US54055E1047) traded at 47.04 USD on September 1, 2026, while the latest market snapshot showed a 5-day change of -3.25 percent and a year-to-date gain of 109.81 percent.
Market move stays visible
MarketScreener showed the stock closed on Cboe at 47.04 USD with a daily move of -0.20 percent as of September 1, 2026. That leaves the share price far above the start of the year, even after the recent pullback.
For investors, the gap between the 5-day slip and the 109.81 percent year-to-date advance is the clearest signal in the tape.
What the chart says
The same snapshot points to a stock that remains expensive in momentum terms, with the price still near its annual highs relative to the early-year base. The move was visible even on a day when the broader US market was weak.
Longboard Pharmaceuticals stock facts
Key market data and company details for LBPH, including the latest price snapshot and trading venue.
Longboard Pharma pipeline
Longboard Pharmaceuticals develops therapies for serious neurological diseases, and that pipeline backdrop keeps the stock tied to clinical milestones rather than conventional sales growth. The market snapshot does not add fresh operating figures, so the pricing action carries most of the current signal.
Closing stock view
LBPH stock closed at 47.04 USD on September 1, 2026, according to the market snapshot. The same data set also showed a 5-day change of -3.25 percent and a year-to-date gain of 109.81 percent.
LBPH facts
- Company: Longboard Pharmaceuticals Inc.
- ISIN: US54055E1047
- Ticker: LBPH
- Trading venue: Nasdaq
- Price (as of September 1, 2026, 20:59): 47.04 USD
- Market capitalization: not available in the retrieved market snapshot
- Sector / Industry: Pharmaceuticals / Biotechnology
- Index membership: Nasdaq Composite
